Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP858749.RARup7c-js4Ad62Z4DUheympKyllkhYfik2pA8wVoJTZc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP858749.RARup7c-js4Ad62Z4DUheympKyllkhYfik2pA8wVoJTZc130_assertion type Assertion NP858749.RARup7c-js4Ad62Z4DUheympKyllkhYfik2pA8wVoJTZc130_head.
- NP858749.RARup7c-js4Ad62Z4DUheympKyllkhYfik2pA8wVoJTZc130_assertion description "[HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP858749.RARup7c-js4Ad62Z4DUheympKyllkhYfik2pA8wVoJTZc130_provenance.
- NP858749.RARup7c-js4Ad62Z4DUheympKyllkhYfik2pA8wVoJTZc130_assertion evidence source_evidence_literature NP858749.RARup7c-js4Ad62Z4DUheympKyllkhYfik2pA8wVoJTZc130_provenance.
- NP858749.RARup7c-js4Ad62Z4DUheympKyllkhYfik2pA8wVoJTZc130_assertion SIO_000772 21153051 NP858749.RARup7c-js4Ad62Z4DUheympKyllkhYfik2pA8wVoJTZc130_provenance.
- NP858749.RARup7c-js4Ad62Z4DUheympKyllkhYfik2pA8wVoJTZc130_assertion wasDerivedFrom befree-2016 NP858749.RARup7c-js4Ad62Z4DUheympKyllkhYfik2pA8wVoJTZc130_provenance.
- NP858749.RARup7c-js4Ad62Z4DUheympKyllkhYfik2pA8wVoJTZc130_assertion wasGeneratedBy ECO_0000203 NP858749.RARup7c-js4Ad62Z4DUheympKyllkhYfik2pA8wVoJTZc130_provenance.